All Stories

  1. EACVI survey on the use of multi-modality cardiovascular imaging in immune-mediated inflammatory diseases
  2. An EACVI survey assessing the awareness of cardiovascular imaging's environmental impact among cardiovascular imagers
  3. European Association of Cardiovascular Imaging survey on imaging for myocardial viability
  4. EACVI survey on evaluation and quantification of aortic regurgitation by multi-modality imaging
  5. Asymptomatic severe degenerative mitral regurgitation
  6. Identification and characterization of necrotic tumour using contrast-enhanced echocardiography
  7. High-definition blood flow imaging improves quantification of left ventricular volumes and ejection fraction
  8. Determinants of post-operative left ventricular dysfunction in degenerative mitral regurgitation
  9. Usefulness of contrast enhanced cardiac ultrasound to assess vascularity in cardiac mass of unknown aetiology
  10. Care of the patient after valve intervention
  11. Mitral regurgitation management: a systematic review of clinical practice guidelines and recommendations
  12. Blood biomarkers in patients with repaired Tetralogy of Fallot (rTOF); A systematic review and meta-analysis
  13. Vaccine-induced immune thrombocytopenia and thrombosis associated anterior ST-elevation myocardial infarction
  14. Moderate Aortic Stenosis: What is it and When Should We Intervene?
  15. Incidence of Cabergoline-Associated Valvulopathy in Primary Care Patients With Prolactinoma Using Hard Cardiac Endpoints
  16. Association between mitral annular calcification and progression of mitral and aortic stenoses
  17. Racial differences in the aetiology of mitral valve disease
  18. Mortality Whilst Waiting For Intervention In Symptomatic Severe Aortic Stenosis
  19. ‘Valvular’ AL amyloidosis
  20. Inconsistency in aortic stenosis severity between CT and echocardiography: prevalence and insights into mechanistic differences using computational fluid dynamics
  21. Mitral valve prolapse
  22. Stress echocardiography in valvular heart disease
  23. Does presence of left ventricular contractile reserve improve response to cardiac resynchronization therapy? An updated meta-analysis
  24. Classification of Aortic Stenosis by Flow and Gradient Patterns Provides Insights into the Pathophysiology of Disease
  25. Disintegration of polyvinyl alcohol membrane covering atrial septal defect closure device:
  26. Dynamic Mitral Regurgitation
  27. Prevalence & composition of heart valve multi-disciplinary teams within a national health system
  28. Comprehensive assessment of complications of infective endocarditis by 3D transesophageal echocardiography
  29. The Feasibility and Clinical Utility of Myocardial Contrast Echocardiography in Clinical Practice: Results from the Incorporation of Myocardial Perfusion Assessment into Clinical Testing with Stress Echocardiography Study
  30. SIMULTANEOUS MYOCARDIAL PERFUSION ASSESSMENT DURING MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY PROVIDES INCREMENTAL PROGNOSTIC VALUE BEYOND WALL MOTION ANALYSIS WHEN INCORPORATED INTO A REAL-WORLD CLINICAL STRESS ECHOCARDIOGRAPHY SERVICE
  31. Development of a National Echocardiography Quality Improvement Programme: insights into feasibility, uptake, and clinical utility
  32. Comprehensive cardiovascular MRI in hypertension: a UK single centre experience
  33. Cardiac tumors: the role of cardiovascular imaging
  34. Clinical Utility and Prognostic Value of Appropriateness Criteria in Stress Echocardiography for the Evaluation of Valvular Heart Disease
  35. Cardiac manifestations of gastrointestinal carcinoid tumor
  36. Characterisation of left ventricular myocardial fibrosis in adult congenital heart disease by contrast and deformation echocardiography validated by CMR
  37. Characterisation of intra-cardiac masses by myocardial contrast echocardiography
  38. Outcomes, risks and complications of cardiac surgery for carcinoid heart disease
  39. Risk Factors for the Development and Progression of Carcinoid Heart Disease
  40. Surgery for carcinoid heart disease: current outcomes, concerns and controversies
  41. Drug-induced fibrotic valvular heart disease
  42. A stepwise approach to the management of metastatic midgut carcinoid tumor
  43. Cytochrome P450 2C19 polymorphism and clopidogrel after MI
  44. Usefulness of N-terminal Pro–Brain Natriuretic Peptide as a Biomarker of the Presence of Carcinoid Heart Disease
  45. Metastatic rectal adenocarcinoma within haemorrhoids: a case report
  46. Periodontal disease in a patient receiving Bevacizumab: a case report
  47. Analysis of 150 Patients With Carcinoid Syndrome Seen in a Single Year at One Institution in the First Decade of the Twenty-First Century
  48. Autoimmune neutropenia following therapy for chronic lymphocytic leukaemia: a report of three cases